5 ways doctors show bias in choosing patients for trials
Time, language and cultural barriers may limit minority recruitment for cancer trials: survey

Doctors’ and researchers’ biases may be one reason minority participation in trials is generally low, a study suggests.
A survey of healthcare professionals involved in US clinical trials has found minority patients often are not considered “optimal” choices, researchers report in Cancer.